TuHURA Accounts Payable vs Total Liab Analysis
| HURA Stock | 4.41 0.14 3.08% |
TuHURA Biosciences financial indicator trend analysis is much more than just breaking down TuHURA Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TuHURA Biosciences is a good investment. Please check the relationship between TuHURA Biosciences Accounts Payable and its Total Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.
Accounts Payable vs Total Liab
Accounts Payable vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TuHURA Biosciences Accounts Payable account and Total Liab. At this time, the significance of the direction appears to have pay attention.
The correlation between TuHURA Biosciences' Accounts Payable and Total Liab is -0.87. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Liab in the same time period over historical financial statements of TuHURA Biosciences, assuming nothing else is changed. The correlation between historical values of TuHURA Biosciences' Accounts Payable and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of TuHURA Biosciences are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Accounts Payable i.e., TuHURA Biosciences' Accounts Payable and Total Liab go up and down completely randomly.
Correlation Coefficient | -0.87 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents TuHURA Biosciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of TuHURA Biosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from TuHURA Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TuHURA Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.As of December 28, 2024, Selling General Administrative is expected to decline to about 3.1 M. Issuance Of Capital Stock is expected to grow at the current pace this year
| 2023 | 2024 (projected) | Total Operating Expenses | 29.8M | 18.8M | Cost Of Revenue | 28.8K | 25.6K |
TuHURA Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
TuHURA Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.